Psychiatry and Neurology, Neurology · Ocala, FL
NPI
1770658957
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1724 SE 17th Ave
Ocala, FL, 34471
Phone (352) 901-6210
Groups this clinician bills Medicare through
Medicare paid, 2024
$346K
16,154 services
Medicare patients, 2024
867
Average age 78
Drug cost, 2024
$1.7M
6,158 prescriptions
Company payments, 2025
$3,899
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anette Nieves was code J0585 (injection, onabotulinumtoxina, 1 unit), 12,345 times for 25 patients. In total Anette Nieves billed 16,154 services in 33 codes, and Medicare paid $346K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 12,345 | 25 | $4.90 | $60K |
| 99214 Office E&M - Established | Office | 1,266 | 647 | $96.17 | $122K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 689 | 231 | $38.15 | $26K |
| 99213 Office E&M - Established | Office | 390 | 308 | $64.82 | $25K |
| 99215 Office E&M - Established | Office | 333 | 242 | $137.79 | $46K |
| 99204 Office E&M - New | Office | 163 | 163 | $124.67 | $20K |
| 11105 Skin Biopsy | Office | 74 | 37 | $45.34 | $3,355 |
| 99442 Telephone Services | Office | 68 | 61 | $67.79 | $4,610 |
| 99205 Office E&M - New | Office | 66 | 66 | $162.50 | $11K |
| 99441 Telephone Services | Office | 66 | 60 | $41.57 | $2,743 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 40 | 37 | $12.81 | $512 |
| 11104 Skin Biopsy | Office | 37 | 37 | $94.70 | $3,504 |
| 64615 Musculoskeletal | Office | 26 | 13 | $117.56 | $3,057 |
| 99203 Office E&M - New | Office | 23 | 23 | $86.46 | $1,989 |
| 99443 Telephone Services | Office | 13 | 12 | $99.13 | $1,289 |
By year: 2022 $172K for 4,623 services; 2023 $274K for 9,849 services; 2024 $346K for 16,154 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anette Nieves prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,023 prescriptions and refills. In total Anette Nieves wrote 6,158 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,023 | 2,700 | 350 | $41K |
| Memantine Hcl Generic | 688 | 1,501 | 220 | $26K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 469 | 1,246 | 153 | $21K |
| Donepezil Hcl Generic | 419 | 1,062 | 154 | $5,505 |
| Quetiapine Fumarate Generic | 230 | 474 | 76 | $5,490 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 228 | 598 | 77 | $8,186 |
| Escitalopram Oxalate Generic | 221 | 460 | 69 | $2,887 |
| Sertraline Hcl Generic | 206 | 460 | 64 | $1,401 |
| Primidone Generic | 172 | 438 | 62 | $5,212 |
| Buspirone Hcl Generic | 161 | 304 | 61 | $1,678 |
| Amantadine Amantadine Hcl | 161 | 386 | 60 | $11K |
| Gabapentin Generic | 147 | 397 | 57 | $3,788 |
| Duloxetine Hcl Generic | 125 | 267 | 37 | $3,391 |
| Rytary Carbidopa/Levodopa | 120 | 210 | 31 | $190K |
| Ropinirole Hcl Generic | 109 | 312 | 36 | $7,656 |
Brand drugs: 387 claims; generic drugs: 5,771 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anette Nieves $3,899 ($3,899 in general payments such as food, travel and fees) from 30 companies. The largest payer was F. Hoffmann-La Roche AG with $1,200.
| Company | Payments | Amount |
|---|---|---|
| F. Hoffmann-La Roche AG ROG.SW | 2 | $1,200 |
| Abbvie Inc. ABBV | 22 | $387 |
| Eisai Inc. 4523.T | 14 | $382 |
| Teva Pharmaceuticals USA, Inc. TEVA | 18 | $339 |
| Amneal Pharmaceuticals LLC AMRX | 10 | $202 |
| ACADIA Pharmaceuticals Inc ACAD | 8 | $194 |
| Neurocrine BioSciences, Inc. NBIX | 9 | $191 |
| Supernus Pharmaceuticals, Inc. SUPN | 13 | $156 |
| Lundbeck LLC | 7 | $148 |
| MDD US Operations, LLC | 11 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.